Regadenoson
Sign in to saveAlso known as Rapiscan®, Lexiscan®, regadenoson anhydrous, CVT-3146, Regadenoson anhydrous
Regadenoson, sold under the brand name Lexiscan among others, is an A2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing. It produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging. The selective nature of the drug makes it preferable to other stress agents such as adenosine, which are less selective and therefore cause more side-effects.
Research
549 papers- Regadenoson.2006
- Regadenoson.Journal of postgraduate medicine · 2012
- Regadenoson Stress Testing: A Comprehensive Review With a Focused Update.Cureus · 2021
- Regadenoson: a focused update.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013
- Regadenoson.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2010
via PubMed
Wikidata facts
- Mass
- 390.14
Show 5 more facts
- chemical formula
- C₁₅H₁₈N₈O₅
- isomeric SMILES
- CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O
- canonical SMILES
- CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3C4C(C(C(O4)CO)O)O
- defined daily dose
- 0.4
- Commons category
- Regadenoson
via Wikidata · CC0
~3 min read
Article
1 sectionsContents
- References
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 413312613 | IUPAC_name = 2-{4-[(methylamino)carbonyl]- 1H-pyrazol-1-yl}adenosine | image = Regadenoson structure.svg | image_class = skin-invert-image | width = 300
| tradename = Lexiscan, Rapiscan | Drugs.com = | DailyMedID = Regadenoson | pregnancy_AU = | pregnancy_category = | routes_of_administration = Intravenous | ATC_prefix = C01 | ATC_suffix = EB21 | ATC_supplemental =